Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05221281Not ApplicableActive Not Recruiting

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Role: collaborator

NCT05722236Not ApplicableRecruiting

IBD Strong Peer2Peer for Self-Management of Psychological Distress

Role: collaborator

NCT04202211Phase 2Withdrawn

FMT for Remission of Active Ulcerative Colitis in Adults

Role: collaborator

NCT03091309Not ApplicableUnknown

Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease

Role: collaborator

NCT02931799Not ApplicableUnknown

Prevention of Readmissions at IBD Centres of Excellence

Role: collaborator

NCT03239704Not ApplicableUnknown

Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease

Role: collaborator

NCT02945488Not ApplicableTerminated

Exercise and Nutrition in IBD & Preconception

Role: collaborator

NCT02093767Not ApplicableCompleted

Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis

Role: collaborator

All 8 trials loaded